Karo Pharma AB Stock
Karo Pharma AB Stock
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Karo Pharma AB.
With a target price of 56 € there is potential for a 929.41% increase which would mean more than doubling the current price of 5.44 € for Karo Pharma AB.
Pros and Cons of Karo Pharma AB in the next few years
Pros
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Karo Pharma AB vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Karo Pharma AB | - | - | - | - | - | - | - |
| Medivir AB | -13.440% | 7.522% | 22.111% | 3.994% | 328.824% | -74.897% | -84.907% |
| NanoViricides Inc. | -0.760% | -1.504% | 12.931% | -2.963% | 40.860% | -5.072% | -61.357% |
| Ocuphire Pharma Inc. | -1.240% | 18.382% | -9.551% | 246.609% | 91.439% | -17.857% | -9.551% |
Comments
Karooooo (KARO) had its price target raised by Raymond James Financial, Inc. from $60.00 to $75.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by Roth Capital.
Show more
Ratings data for KARO provided by MarketBeat
Karooooo (KARO) had its "buy" rating reaffirmed by UBS Group AG.
Show more
Ratings data for KARO provided by MarketBeat